A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this protocol is to acquire pilot data for a larger study to test the following hypothesis: Treatment of the hands of patients with chronic hand dermatitis/atopic dermatitis with CLn BodyWash, a novel gel wash cleanser currently marketed as a cosmetic product containing a dilute concentration of less than 0.01% sodium hypochlorite and less than 0.005% concentration as it is lathered, will result in a statistically significant reduction in the number of skin fauna present on the hands of these patients compared to treatment of such patients with traditional wash used clinically such as Cetaphil Daily Facial Cleanser.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

NCT01714245

Eczema Atopic Dermatitis

COMPLETED

Evaluating the Effects of Cleansers on the Skin

NCT03188653

Atopic Dermatitis

TERMINATED NA

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

NCT01063218

Dermatitis, Atopic

COMPLETED PHASE4

FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults

NCT01950494

Hand Dermatitis

COMPLETED NA

An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis

NCT00806221

Atopic Dermatitis

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with Hand Eczema will be asked to wash with either a CLn BodyWash or Cetaphil Daily Facial Cleanser. Patients and study staff will be blinded. Hand swabs will be done prior to the wash and after 20 minutes. The average time spent in the study for each patient should be less than 2 hours unless an Adverse Event occurs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eczema Hand Eczema Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CLn BodyWash

CLn BodyWash will be used to wash hands of patients with Hand Atopic Dermatitis

Group Type ACTIVE_COMPARATOR

CLn BodyWash

Intervention Type OTHER

Comparing two washes to determine change in bacterial load.

Cetaphil Daily Facial Cleanser

Cetaphil Daily Facial Cleanser will be used to wash hands of patients with Hand Atopic Dermatitis

Group Type ACTIVE_COMPARATOR

Cetaphil Daily Facial Cleanser

Intervention Type OTHER

Comparing two washes to determine change in bacterial load.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CLn BodyWash

Comparing two washes to determine change in bacterial load.

Intervention Type OTHER

Cetaphil Daily Facial Cleanser

Comparing two washes to determine change in bacterial load.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cetaphil Daily Facial

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Seen by an OSU Dermatology provider at OSU Dermatology East after the date of approval of this protocol
* Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
* Willingness to participate in a research study.
* Diagnosis of chronic hand dermatitis